Influence of a new diabetesmedicine on cholesterol and other factors after intake of a fatty meal in patients with diabetes
- Registry ID
- EUCTR2016-001417-24
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE4
- Sponsor
- Franciscus Gasthuis
- Start date
- 2016-11-08
- Last update
- 2026-08-16
Conditions
- Diabetes Mellitus type II
Summary
To explore the effects of dapagliflozin compared with placebo on postprandial leukocyte activation markers in men with type 2 diabetes mellitus.
Locations
View on source registry